Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-24680952

RESUMO

We studied the effects of three newly synthesized steroidal derivatives of nitrogen mustards, alone or in combination with caffeine, on sister chromatid exchange (SCE) frequencies and on human lymphocyte proliferation kinetics. The agents have as alkylator functionalities either P-N,N-bis(2-chloroethyl)aminophenyl-buturate (CHL) or P-N,N-bis(2-chloroethyl)aminophenyl-acetate (PHE), esterified with a modified steroidal nucleus. An enhancement of SCE frequency was seen with compounds which contain either PHE or CHL as alkylators and are esterified with a steroidal nucleus having added a cholestene group in the 17-position of the D-ring. The exocyclic insertion of an -NHCO- group in the D-ring of the steroidal nucleus esterified with PHE (amide ester of PHE) gave a compound showing increased SCE frequency. Enhanced cytogenetic damage was observed when lymphocytes were exposed in vitro to caffeine. The compounds, alone or in combination with caffeine, caused a concentration-dependent increase in SCE frequencies and cell division delays, and caffeine was found to act synergistically with the steroidal alkylators.


Assuntos
Antineoplásicos Alquilantes , Cafeína , Núcleo Celular/metabolismo , Estimulantes do Sistema Nervoso Central , Aberrações Cromossômicas/induzido quimicamente , Linfócitos/metabolismo , Compostos de Mostarda Nitrogenada , Troca de Cromátide Irmã/efeitos dos fármacos , Adulto , Antineoplásicos Alquilantes/efeitos adversos , Antineoplásicos Alquilantes/agonistas , Antineoplásicos Alquilantes/farmacologia , Cafeína/efeitos adversos , Cafeína/agonistas , Cafeína/farmacologia , Núcleo Celular/genética , Núcleo Celular/patologia , Estimulantes do Sistema Nervoso Central/efeitos adversos , Estimulantes do Sistema Nervoso Central/agonistas , Estimulantes do Sistema Nervoso Central/farmacologia , Sinergismo Farmacológico , Feminino , Humanos , Linfócitos/patologia , Masculino , Compostos de Mostarda Nitrogenada/efeitos adversos , Compostos de Mostarda Nitrogenada/agonistas , Compostos de Mostarda Nitrogenada/farmacologia , Esteroides/efeitos adversos , Esteroides/agonistas , Esteroides/farmacologia
2.
Angiology ; 60(6): 772-9, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19190027

RESUMO

INTRODUCTION: Advanced glycation end products (AGEs) engagement of a monocyte surface receptor (RAGE) induces atherosclerosis. AGEs also act as CD36 ligands. We studied reactive oxygen species (ROS) and CD36 expression after siRNA inhibition of RAGE expression in human monocytes. METHODS: We isolated monocytes from: a) 10 type 2 diabetics, and b) 5 age- and sex-matched healthy individuals. CD36 expression and ROS production were evaluated before and after RAGE knockdown. RESULTS: After incubation of monocytes with AGE + bovine serum albumin (BSA), CD36 expression and intracellular ROS increased significantly in all groups. In RAGE-knockdown monocytes, AGE-induced CD36 expression and ROS generation were also significantly inhibited. CONCLUSIONS: Blocking RAGE expression using siRNA in human monocytes led to a significant inhibition of CD36 expression and ROS production, suggesting a positive interaction between RAGE, CD36 expression and ROS generation in monocytes.


Assuntos
Antígenos CD36/genética , Diabetes Mellitus Tipo 2/sangue , Regulação da Expressão Gênica , Monócitos/metabolismo , RNA Interferente Pequeno/genética , Espécies Reativas de Oxigênio/sangue , Receptores Imunológicos/metabolismo , Idoso , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Antígenos CD36/biossíntese , Antígenos CD36/efeitos dos fármacos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/genética , Feminino , Produtos Finais de Glicação Avançada , Humanos , Masculino , Pessoa de Meia-Idade , RNA Interferente Pequeno/efeitos dos fármacos , Receptor para Produtos Finais de Glicação Avançada , Espectrometria de Fluorescência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA